Anders Fink-Jensen

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Acta psychiatrica Scandinavica

Psychological medicine

Basic & clinical pharmacology & toxicology

CNS spectrums

Region Hovedstadens Psykiatri

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Region Hovedstadens Psykiatri

Denmark

Professor :: Psykiatrisk Center København

Publications

Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen, Ema Gruber, Helle Nerdrum, Lone Marianne Pedersen, Maximilian Resch, Troels Højsgaard Jørgensen, Claus Thorn Ekstrøm, Jimmi Nielsen, Tina Vilsbøll, Anders Fink-Jensen
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study. Acta psychiatrica Scandinavica 150 (1) (2024)
Lorenzo Leggio, Christian S Hendershot, Mehdi Farokhnia, Anders Fink-Jensen, Mette Kruse Klausen, Joseph P Schacht, W Kyle Simmons
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders. Nature medicine (2023)
Mikkel Hojlund, Christina Blanner Kristiansen, Rikke Wesselhoeft, Kjeld Andersen, Anders Fink-Jensen, Nina Sahlertz Kristiansen
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study. Basic & clinical pharmacology & toxicology 130 (4) (2022)
Corinde E Wiers, Leandro F Vendruscolo, Jan-Willem van der Veen, Peter Manza, Ehsan Shokri-Kojori, Danielle S Kroll, Dana E Feldman, Katherine L McPherson, Catherine L Biesecker, Rui Zhang, Kimberly Herman, Sophie K Elvig, Janaina C M Vendruscolo, Sara A Turner, Shanna Yang, Melanie L Schwandt, Dardo Tomasi, Mackenzie C Cervenka, Anders Fink-Jensen, Helene Benveniste, Nancy Diazgranados, Gene-Jack Wang, George F Koob, Nora D Volkow
Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents. Science advances 7 (15) (2021)
Magnus G Christensen, Jakob Damsgaard, Anders Fink-Jensen
Use of ketogenic diets in the treatment of central nervous system diseases: a systematic review. Nordic journal of psychiatry 75 (1) (2020)
Birgitte Fagerlund, Christos Pantelis, Jens Richardt Moellegaard Jepsen, Jayachandra Mitta Raghava, Egill Rostrup, Marie Bjerregaard Thomas, Mette Ødegaard Nielsen, Kirsten Borup Bojesen, Karsten Gjessing Jensen, Marie Stentebjerg-Decara, Dea Gowers Klauber, Ditte Rudå, Bjørn H Ebdrup, Kasper Jessen, Anne Sigvard, Karen Tangmose, Pia Jeppesen, Christoph U Correll, Anders Fink-Jensen, Anne Katrine Pagsberg, Birte Yding Glenthøj
Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years. Psychological medicine 51 (9) (2020)
Marco Møller, Simon Fredholm, Mathias E Jensen, Gitta Wörtwein, Julie R Larsen, Tina Vilsbøll, Niels Odum, Anders Fink-Jensen
Proinflammatory biomarkers are associated with prediabetes in patients with schizophrenia. CNS spectrums (2020)
Annika Billefeld Bornebusch, Anders Fink-Jensen, Gitta Wörtwein, Randy J Seeley, Morgane Thomsen
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs. eNeuro 6 (2) (2019)
Morgane Thomsen, Jens Juul Holst, Anna Molander, Kristian Linnet, Maurice Ptito, Anders Fink-Jensen
Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Psychopharmacology 236 (2) (2018)
Ditte Dencker, Anna Molander, Morgane Thomsen, Chantal Schlumberger, Gitta Wortwein, Pia Weikop, Helene Benveniste, Nora D Volkow, Anders Fink-Jensen
Ketogenic Diet Suppresses Alcohol Withdrawal Syndrome in Rats. Alcoholism, clinical and experimental research 42 (2) (2017)

Anders Fink-Jensen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anders Fink-Jensen